Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2026-07-27

Clinical Trial Update: Clinical Efficacy and Safety of MB LuxuryⓇ Product Containing Epigallocathecin Gallate (EGCG) on Erythema, Melanin, and Skin Hydration [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial evaluating MB Luxury product containing EGCG for hyperpigmentation and skin conditions, reporting on efficacy and safety related to erythe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MB Luxury (epigallocatechin gallate (EGCG) containing product)

Snippet

Sponsor: Naniek Widyaningrum | Conditions: Hyperpigmentation, Dry Skin | Phase 2, Phase 3 | Status: COMPLETED